Suzanne Fleming

Suzanne Fleming is a seasoned finance executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Senior Vice President of Finance at Beam Therapeutics Inc. since 2019, Suzanne has held senior roles in various organizations, including Senior Vice President of Finance at Epizyme and Vice President of Finance at Foundation Medicine. Other key positions include Vice President and Chief Accounting Officer at Aegerion Pharmaceuticals, Vice President of Finance at AVEO Oncology, and Senior Director of Finance at Transform Pharmaceuticals, among others. Suzanne's career began as Controller at Oculon Corporation, with progressively responsible roles leading to significant financial leadership throughout their career.